Internal restructuring
Östra Mellansverige; Uppsala län;
Location of affected unit(s)
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72 - Scientific research and development

110 jobs
Number of planned job losses
Job loss
Announcement Date
31 May 2011
Employment effect (start)
6 June 2011
Foreseen end date
7 November 2011


The clinical research company Quintiles gave notice to 110 employees in Uppsala. The dismissal is due to the fact that the market for clinical drug has declined in recent years and demand for clinical trials has been greatly reduced. 

Quintiles Sweden combines clinical specialist facilities and scientific expertise to provide complete pharmaceutical development services. The company has been operating in Sweden since 1995 and currently has 200 employees. It is a subsidiary of the US American pharmaceutical services company Quintiles Transnational.

Quintiles Transnational is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. The company employs around 22,000 employees in 60 countries.


  • 31 May 2011: Unt.se


Eurofound (2011), Quintiles, Internal restructuring in Sweden, factsheet number 72045, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/72045.